Last month, I had the privilege of attending the DIA 2024 conference, the premier event for professionals in drug development and regulatory affairs. Often, this group of 5,000 clinical research professionals are working at desks, computers, and buried in spreadsheets and systems, navigating the complicated and complex industry that is clinical research. But this conferenceRead more